Fixed Triple-Combination Bimatoprost/Brimonidine/Timolol Versus Separate Administration in Glaucoma: Randomized Clinical Trial
Both regimens achieved similar efficacy but were associated with progressive hyperemia, reduced QoL, and low persistence, underscoring the limitations of multiple topical glaucoma therapy.
Authors
- Tiago S. Prata (ORCID: https://orcid.org/0000-0003-1830-3766)
- André Hiroshi Bando
- A Paranhos-Jr
- Mariana Kawamuro
- Carolina PB Gracitelli
- Lilian F. Machado
- Giovanna Aiko Wada
- Luana Andrioli Parmigiani
- Sérgio H. Teixeira
- Ricardo Abe
- Lucca Sokabe
Institutions
- Hospital Oftalmologico de Brasília (BR)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Journal of Ocular Pharmacology and Therapeutics
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1177/10807683261421428
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00